ACE inhibitor quinapril in the treatment of chronic cardiac failure
Aim. To assess effectiveness of A CE inhibitor quinapril in patients with moderate cardiac failure of ischemic etiology. Material and methods. 20 patients received quinapril in a daily dose 20 mgfor 6 months. Clinical condition, exercise tolerance, functional and geometric parameters of the left ven...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2003-01-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/29292 |
Summary: | Aim. To assess effectiveness of A CE inhibitor quinapril in patients with moderate cardiac failure of ischemic etiology.
Material and methods. 20 patients received quinapril in a daily dose 20 mgfor 6 months. Clinical condition, exercise tolerance, functional and geometric parameters of the left ventricle, Hotter monitoring, heart rhythm variability, late potentials were studied before and after the treatment. Results. The treatment relieved symptoms significantly, exercise tolerance increased, positive changes occurred in systotic, diastolic functions and left ventricular geometry. Ischemic episodes, supraventricular extrasystoles reduced in number and duration. Conclusion. Quinapril is an effective drug for treatment of moderate ischemic heart failure. |
---|---|
ISSN: | 0040-3660 2309-5342 |